{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/SeikyoApp/my-repo/blob/main/ClinicalTrials_gov_API.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "参考サイト：https://clinicaltrials.gov/data-api/about-api/api-migration#other-all-api-xml"
      ],
      "metadata": {
        "id": "83notgfu_uXV"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 836
        },
        "id": "-AjKp2Q08w7A",
        "outputId": "cbd87a37-6abf-490d-8199-c72812591d5f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "📌 APIレスポンスの一部を確認:\n",
            "{'studies': [{'protocolSection': {'identificationModule': {'nctId': 'NCT03437876', 'briefTitle': 'Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis', 'officialTitle': 'A Randomised Study on Intestinal Microbiota Transplantation for Hepatitis B Virus Induced Cirrhosis'}, 'statusModule': {'overallStatus': 'UNKNOWN', 'startDateStruct': {'date': '2016-10-31'}, 'primaryCompletionDateStruct': {'date': '2020-11'}, 'completionDateStruct': {'date': '2020-12'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Zhongshan Hospital Xiamen University'}}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'enrollmentInfo': {'count': 60}}, 'armsInterventionsModule': {'interventions': [{'type': 'OTHER', 'name': 'intestinal microbiota transplant'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Inclusion Criteria:\\n\\n* Written informed consent/assent as appropriate, able to keep treatment\\n* 18 to 50 years of age\\n* Chronic hepatitis B, definitely diagnosed as hepatic fibrosis/cirrhosis through Fibroscan/Biopsy of liver biopsy\\n\\nExclusion Criteria:\\n\\n* Drug treatment(immunosuppressive drugs, biological agents, high dose vitamins or other immunosuppressive drugs\\n* Other immune related diseases\\n* Gastrointestinal organic lesions such as gastroesophageal reflux disease, inflammatory bowel disease, intestinal tumor\\n* Medical or social condition which in the opinion of the principal investigator would interfere with or prevent regular follow up\\n* Participating in other clinical trials', 'sex': 'ALL', 'minimumAge': '18 Years', 'maximumAge': '50 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Zhongshan Hospital Affiliated to Xiamen University', 'city': 'Xiamen', 'country': 'China'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT00252876', 'briefTitle': 'GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes', 'officialTitle': 'An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.'}, 'statusModule': {'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2005-03'}, 'completionDateStruct': {'date': '2007-01'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AstraZeneca'}}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'enrollmentInfo': {'count': 2000}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'tesaglitazar'}]}, 'eligibilityModule': {'eligibilityCriteria': \"Inclusion Criteria:\\n\\n* Provision of a written informed consent\\n* Men or women who are \\\\>=18 years of age\\n* Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control\\n* Completed the last two visits of randomized treatment period in GALLANT 2/22, 5, 7, 8 or 14 studies.\\n\\nExclusion Criteria:\\n\\n* Type 1 diabetes\\n* New York Heart Association heart failure Class III or IV\\n* Treatment with chronic insulin\\n* History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)\\n* History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)\\n* Creatinine levels above twice the normal range\\n* Creatine kinase above 3 times the upper limit of normal\\n* Previous enrollment in this long-term extension study\\n* Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study\", 'sex': 'ALL', 'minimumAge': '18 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Research Site', 'city': 'Birmingham', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Columbiana', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Mobile', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Carlisle', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Sherwood', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Chula Vista', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Escondido', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Huntington Beach', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Los Angeles', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Mission Viejo', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Orange', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Pasadena', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Redondo Beach', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Sacramento', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Colorado Springs', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Wheat Ridge', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Clearwater', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Gainesville', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Hollywood', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Jacksonville', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Miami', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'West Palm Beach', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Atlanta', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Brunswick', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Honolulu', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Boise', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Evansville', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Witchita', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Bossier City', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'New Orleans', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Baltimore', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Kalamazoo', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Las Vegas', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Pahrump', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Hamilton', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Albuquerque', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Bronx', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'New York', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Rochester', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'White Plains', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Charlotte', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Cincinnati', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Dayton', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Kettering', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Oklahoma City', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Medford', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Philadelphia', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Simpsonville', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Morristown', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Corpus Christi', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Dallas', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'San Antonio', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Burke', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Norfolk', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Richmond', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Tacoma', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Menomonee Falls', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Milwaukee', 'country': 'United States'}, {'facility': 'Research Site', 'city': 'Moron', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Quilmes', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Ciudad de Buenos Aires', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Córdoba', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Rosario', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Salta - Salta', 'country': 'Argentina'}, {'facility': 'Research Site', 'city': 'Adelaide', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Brisbane', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Cairns', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Geelong', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Melbourne', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Perth', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Sydney', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Tasmania', 'country': 'Australia'}, {'facility': 'Research Site', 'city': 'Curitiba', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'Fortaleza', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'Goiânia', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'Porto Alegre', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'Ribeirão Preto', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'São Paulo', 'country': 'Brazil'}, {'facility': 'Research Site', 'city': 'Calgary', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Coquitlam', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Surrey', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Winnipeg', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Bay Roberts', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Mount Pearl', 'country': 'Canada'}, {'facility': 'Research Site', 'city': \"St. John's\", 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Bolton', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Brampton', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Hamilton', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Hastings', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Kingston', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'London', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Napanee', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'North York', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Ottawa', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Smith Falls', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Toronto', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Chomedey-Laval', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Laval', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Montréal', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Sherbrooke', 'country': 'Canada'}, {'facility': 'Research Site', 'city': 'Brno', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Hodonin', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Hradec Kralove', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Plzen', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Praha 5', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Pribram', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Semily', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Tabor', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Usti nad Labem', 'country': 'Czech Republic'}, {'facility': 'Research Site', 'city': 'Paide', 'country': 'Estonia'}, {'facility': 'Research Site', 'city': 'Pärnu', 'country': 'Estonia'}, {'facility': 'Research Site', 'city': 'Tallinn', 'country': 'Estonia'}, {'facility': 'Research Site', 'city': 'Tartu', 'country': 'Estonia'}, {'facility': 'Research Site', 'city': 'Viljandi', 'country': 'Estonia'}, {'facility': 'Research Site', 'city': 'Helsinki', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Hämeenlinna', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Imatra', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Joensuu', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Kokkola', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Kouvola', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Kuopio', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Lahti', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Mikkeli', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Oulu', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Pietarsaari', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Salo', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Seinajoki', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Tampere', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Turku', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Vaasa', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Vantaa', 'country': 'Finland'}, {'facility': 'Research Site', 'city': 'Belgrade', 'country': 'Former Serbia and Montenegro'}, {'facility': 'Research Site', 'city': 'Athens', 'country': 'Greece'}, {'facility': 'Research Site', 'city': 'Piraeus', 'country': 'Greece'}, {'facility': 'Research Site', 'city': 'Hong Kong', 'country': 'Hong Kong'}, {'facility': 'Research Site', 'city': 'Balatonfüred', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Budapest', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Győr', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Kaposvár', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Kecskemét', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Miskolc', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Siófok', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Székesfehérvár', 'country': 'Hungary'}, {'facility': 'Research Site', 'city': 'Bangalore', 'country': 'India'}, {'facility': 'Research Site', 'city': 'Hyderabad', 'country': 'India'}, {'facility': 'Research Site', 'city': 'Mumbai', 'country': 'India'}, {'facility': 'Research Site', 'city': 'New Delhi', 'country': 'India'}, {'facility': 'Research Site', 'city': 'Jakarta', 'country': 'Indonesia'}, {'facility': 'Research Site', 'city': 'Malang', 'country': 'Indonesia'}, {'facility': 'Research Site', 'city': 'Ashkelon', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Haifa', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Holon', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Jerusalem', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Rishon-Lezion', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Tel Aviv', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Tel Hashomer', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Zefat', 'country': 'Israel'}, {'facility': 'Research Site', 'city': 'Arenzano', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Chiavari (GE)', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Chieri', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Firenze', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Messina', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Milano', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Monteccio Emilia', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Napoli', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Padova', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Pescara', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Piacenza', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Pistoia', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Reggio Calabria', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Reggio Emilia', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Roma', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Scandiano', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Udine', 'country': 'Italy'}, {'facility': 'Research Site', 'city': 'Seoul', 'country': 'Korea, Republic of'}, {'facility': 'Research Site', 'city': 'Suwon', 'country': 'Korea, Republic of'}, {'facility': 'Research Site', 'city': 'Daugavpils', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Jekabpils', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Madona', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Riga', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'SIgulda', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Talsi', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Valmiera', 'country': 'Latvia'}, {'facility': 'Research Site', 'city': 'Vilnius', 'country': 'Lithuania'}, {'facility': 'Research Site', 'city': 'Kubang Kerian', 'country': 'Malaysia'}, {'facility': 'Research Site', 'city': 'Kuala Lumpur', 'country': 'Malaysia'}, {'facility': 'Research Site', 'city': 'Penang', 'country': 'Malaysia'}, {'facility': 'Research Site', 'city': 'Beek en Donk', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Bennebroek', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Den Haag', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Deurne', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Huizen', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Losser', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Nijverdal', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Rijswijk', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Roelofarendsveen', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Rotterdam', 'country': 'Netherlands'}, {'facility': 'Research Site', 'city': 'Cebu City', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Makati', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Manila', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Marikina City', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Pasig City', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Quezon City', 'country': 'Philippines'}, {'facility': 'Research Site', 'city': 'Katowice', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Bialystok', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Bydgoszcz', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Gdansk', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Krakow', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Lodz', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Olsztyn', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Poznan', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Radom', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Rzeszow', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Sopot', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Szczecin', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Toruñ', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Tychy', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Warszawa', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Wroclaw', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Zielona Gora', 'country': 'Poland'}, {'facility': 'Research Site', 'city': 'Almada', 'country': 'Portugal'}, {'facility': 'Research Site', 'city': 'Amadora', 'country': 'Portugal'}, {'facility': 'Research Site', 'city': 'Elvas', 'country': 'Portugal'}, {'facility': 'Research Site', 'city': 'Lisbon', 'country': 'Portugal'}, {'facility': 'Research Site', 'city': 'Portalegre', 'country': 'Portugal'}, {'facility': 'Research Site', 'city': 'Moscow', 'country': 'Russian Federation'}, {'facility': 'Research Site', 'city': 'St. Petersburg', 'country': 'Russian Federation'}, {'facility': 'Research Site', 'city': 'Yaroslavl', 'country': 'Russian Federation'}, {'facility': 'Research Site', 'city': 'Singapore', 'country': 'Singapore'}, {'facility': 'Research Site', 'city': 'Dolny Kubin', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Levice', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Lubochna', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Lucenec', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Nove Zamky', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Povazska Bystrica', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Sahy', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Trencin', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Velky Meder', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Zilina', 'country': 'Slovakia'}, {'facility': 'Research Site', 'city': 'Cape Town', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Chatsworth', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Durban', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Gauteng', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Johannesburg', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Pretoria', 'country': 'South Africa'}, {'facility': 'Research Site', 'city': 'Bern', 'country': 'Switzerland'}, {'facility': 'Research Site', 'city': 'Ilanz', 'country': 'Switzerland'}, {'facility': 'Research Site', 'city': 'Lausanne', 'country': 'Switzerland'}, {'facility': 'Research Site', 'city': 'Monthey', 'country': 'Switzerland'}, {'facility': 'Research Site', 'city': 'Zürich', 'country': 'Switzerland'}, {'facility': 'Research Site', 'city': 'Aberdeen', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Atherstone', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Ayr', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Bath', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Belfast', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Berks', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Birmingham', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Bolton', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Bucks', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Cardiff', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Coventry', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Dundee', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Edinburgh', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Glasgow', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Leeds', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Liverpool', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Manchester', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Northampton', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Plymouth', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Radstock', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Shrewsbury', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Surrey', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'West Bromwich', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Wiltshire', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Wrexham', 'country': 'United Kingdom'}, {'facility': 'Research Site', 'city': 'Hanoi', 'country': 'Vietnam'}, {'facility': 'Research Site', 'city': 'Ho Chi Minh', 'country': 'Vietnam'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT06621576', 'briefTitle': 'First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure', 'officialTitle': 'First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure'}, 'statusModule': {'overallStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2024-09-18'}, 'primaryCompletionDateStruct': {'date': '2025-02'}, 'completionDateStruct': {'date': '2025-09'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Ruijin Hospital'}, 'collaborators': [{'name': 'Shanghai CirCode Biomed Co.,Ltd', 'class': 'INDUSTRY'}, {'name': 'Shanghai Bestudy Medical Technology Co., Ltd', 'class': 'UNKNOWN'}]}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'enrollmentInfo': {'count': 3}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'HM2002 injection'}]}, 'eligibilityModule': {'eligibilityCriteria': \"Inclusion Criteria:\\n\\nSubjects must meet all of the following inclusion criteria:\\n\\n1. be ≥18 and ≤80 years of age at the time of signing the informative and be of either sex;\\n2. have ischemic heart failure (IHF) with left ventricular ejection fraction (LVEF) ≤50% by echocardiography (ECHO), New York Heart Association (NYHA) cardiac function class 3-4, and be proposed to undergo elective coronary artery bypass grafting (CABG);\\n3. voluntarily sign the informed consent form and fully understand the content, process and possible adverse reactions of the trial. Be able to complete the study according to the requirements of the trial protocol and have good compliance;\\n\\nExclusion Criteria:\\n\\nSubjects meeting any of the following criteria will be excluded from this study:\\n\\n1. subjects with the following concomitant symptoms or diseases:\\n\\n   1. ECHO-confirmed LVEF ≤ 20%;\\n   2. History of malignant arrhythmias (including multiple ventricular pre-systole, premature ventricular dystocia, tricyclic rhythm, or ventricular tachycardia) manifesting symptomatically or requiring treatment (CTCAE grade 3);\\n   3. atrial fibrillation (including paroxysmal atrial fibrillation);\\n   4. Long QT syndrome;\\n   5. Estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/1.73 m2; f. Serum gammaglutamyl (GGT) ≤ 1.5 mL/min/1.73 m2\\n   6. Serum alanine aminotransferase (ALT) or aminotransferase (AST) \\\\> 3 x upper limit normal (ULN) and total bilirubin (TBIL) \\\\> 2 x ULN or more;\\n   7. Severe coagulation disorders, bleeding disorders, etc;\\n   8. history of active human immunodeficiency virus (HIV), active hepatitis C virus (HCV), or active hepatitis B virus (HBV); active HIV, HCV, and HBV infections are defined as:\\n\\n   <!-- -->\\n\\n   1. HIV antibody positive;\\n   2. Anti-HCV antibody and positive for HCV RNA;\\n   3. HBsAg positive and HBV DNA ≥1000 cps/ml (or 200 IU/ml); i. current malignancy, or a history of malignancy.\\n2. need for concurrent cardiac or non-cardiac interventional or surgical procedures other than CABG (e.g., valve surgery, ventricular wall tumor surgery, peripheral arterial stenting or surgery)\\n3. patients with prior systemic or cardiac therapy with similar nucleic acid medications\\n4. a known history of drug abuse or drug allergy\\n5. pregnant or lactating women or those who are not using effective contraception;\\n6. other circumstances judged by the investigator to be inappropriate, such as the investigator's judgment that the subject may be exposed to substantial safety risks, or interference with the results of the study, or lack of participation in completing this trial in accordance with the study protocol.\", 'sex': 'ALL', 'minimumAge': '18 Years', 'maximumAge': '80 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Ruijin Hospital Shanghai Jiao Tong University School of Medicine', 'city': 'Shanghai', 'country': 'China'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT02312076', 'briefTitle': 'GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles', 'officialTitle': 'Gonadotropin Releasing Hormone Agonist for Luteal Phase Support in Long Gonadotropin Releasing Hormone Agonist Protocol Cycles'}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2016-09-09'}, 'primaryCompletionDateStruct': {'date': '2024-12-31'}, 'completionDateStruct': {'date': '2024-12-31'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Mansoura University'}}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'enrollmentInfo': {'count': 200}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'Triptorelin'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Inclusion Criteria:\\n\\n* Women subjected to ICSI through controlled ovarian hyperstimulation (COH) with pituitary downregulation by GnRHa.\\n\\nExclusion Criteria:\\n\\n* Moderate or severe endometriosis.\\n* Hydrosalpinx.\\n* Uterine abnormalities.\\n* Myoma.\\n* Previous uterine surgery.', 'sex': 'FEMALE', 'minimumAge': '20 Years', 'maximumAge': '38 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Fertility Care Unit (FCU) in Mansoura University Hospital', 'city': 'Mansourah', 'country': 'Egypt'}, {'facility': 'Private fertility care centers', 'city': 'Mansourah', 'country': 'Egypt'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT05125276', 'briefTitle': 'Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients', 'officialTitle': 'Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients'}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2022-05-13'}, 'primaryCompletionDateStruct': {'date': '2025-07'}, 'completionDateStruct': {'date': '2025-07'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)'}}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'enrollmentInfo': {'count': 3090}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'No aspirin'}, {'type': 'DRUG', 'name': 'Aspirin'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Inclusion Criteria:\\n\\n* Clinical diagnosis of NSTE-ACS (i.e. NSTEMI or unstable angina)\\n* Successful PCI (according to the treating physician)\\n\\nExclusion Criteria:\\n\\n* Known allergy or contraindication for aspirin or all commercially available P2Y12-inhibitors (i.e. ticagrelor, prasugrel and clopidogrel)\\n* Concurrent use of oral anticoagulants (e.g. because of atrial fibrillation)\\n* Ongoing indication for DAPT at admission (e.g. due to recent PCI or ACS)\\n* Planned surgical intervention within 12 months of PCI\\n* Pregnant or breastfeeding women at time of enrolment\\n* Participation in another trial with an investigational drug or device', 'sex': 'ALL', 'minimumAge': '18 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Amsterdam UMC, location AMC', 'city': 'Amsterdam', 'country': 'Netherlands'}, {'facility': 'Amsterdam UMC, location VUmc', 'city': 'Amsterdam', 'country': 'Netherlands'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT03870776', 'briefTitle': 'RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode', 'officialTitle': 'Double-blind,Controlled,Randomized Phase 2 Study of Efficacy,Safety,Pharmacokinetics& Pharmacodynamics of Daily Oral Administration of MAP4343 During 6 Weeks in Antidepressant Non-responders Patients Experiencing a Major Depressive Episode'}, 'statusModule': {'overallStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2019-06-01'}, 'primaryCompletionDateStruct': {'date': '2024-12-01'}, 'completionDateStruct': {'date': '2025-03-01'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Mapreg'}, 'collaborators': [{'name': 'Eurofins Optimed', 'class': 'INDUSTRY'}]}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'enrollmentInfo': {'count': 110}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'MAP4343'}, {'type': 'DRUG', 'name': 'Placebo'}]}, 'eligibilityModule': {'eligibilityCriteria': \"Inclusion Criteria:\\n\\n1. TRD level from to 2 to 4 inclusive according to the Thase \\\\& Rush classification;\\n2. Patient experiencing a Major Depressive Episode (MDE) according to DSM-5 criteria. MDE can be isolated or recurrent. The diagnosis is based on Mini-International Neuropsychiatric Interview (MINI) test;\\n3. Patient who received a previous antidepressant treatment (AD-Y) in monotherapy with vortioxetine, duloxetine or venlafaxine) at optimized dosages during 6 weeks prior to randomization, associated or not to AD-potentiator (quetiapine), are eligible.\\n4. Hamilton Depression Rating Scale (HDRS) score \\\\> 21;\\n5. Clinical Global Impressions scale (CGI) ≥ 4;\\n6. Male or female patient, aged 18 to 80 years inclusive;\\n7. Females of childbearing potential/Sexually active males with partner of childbearing potential: commitment to consistently and correctly use an acceptable method of birth control (oral, transdermal, systemic or implant contraception birth control, intrauterine devices, diaphragm or condoms) for the duration of the trial and for 4 months after the last study drug administration; Females of non-childbearing potential: either surgically sterilized or at least 1 year postmenopausal (amenorrhea duration at least 12 months);\\n8. Negative pregnancy test at screening baseline;\\n9. Body Mass Index (BMI) between 18 and 32 kg/m2 inclusive;\\n10. Laboratory parameters within the normal range of the laboratory (hematological, blood chemistry tests, urinalysis, hormonology). Individual values out of the normal range can be accepted if judged clinically non relevant by the Investigator;\\n11. Normal ECG recording on a 12-lead ECG at the screening visit:\\n\\n    * 120 \\\\< PR \\\\< 210 ms\\n    * QRS \\\\< 120 ms\\n    * QTcF ≤ 430 ms for male and \\\\< 450 ms for female,\\n    * No sign of any trouble of sinusal automatism,\\n    * Or considered NCs by investigators;\\n12. Normal Blood Pressure (BP) and Heart Rate (HR) at the screening visit after 10 minutes in supine position:\\n\\n    * 95 mmHg ≤ Systolic Blood Pressure (SBP) ≤ 140 mmHg,\\n    * 50 mmHg ≤ Diastolic Blood Pressure (DBP) ≤ 90 mmHg,\\n    * 50 bpm ≤ HR ≤ 80 bpm,\\n    * Or considered NCs by investigators;\\n13. Signing a written informed consent prior to selection;\\n14. Covered by Health Insurance System and/or in compliance with the recommendations of National Law in force relating to biomedical research.\\n\\nExclusion Criteria:\\n\\n1. MDE with mood congruent or not congruent psychotic characteristics;\\n2. Patient hospitalized following the procedures: Psychiatric care at the request of another person (soins psychiatriques à la demande d'un tiers) or Psychiatric care at the request of the state representative (soins psychiatriques sur décision du représentant de l'Etat);\\n3. Suicidal risk in the last month before randomization (C-SSRS: answer yes to the item 3 and/or answer yes to section suicidal behavior; MINI 5.00; suicidal risk section or item 3 of HDRS ≥ 3);\\n4. History of other psychiatric disorder than DME except global anxiety, social phobia, panic troubles that should be accepted. In particular, patients who experienced a depressive state in bipolar disorder 1 or 2, schizophrenic or schizoaffective disorder should not be included;\\n5. Presence or history of drug hypersensitivity, or certain allergic-prone condition diagnosed that could represent a risk factor for an allergic shock;\\n6. Presence or history of hypersensitivity to vortioxetine, duloxetine, venlafaxine or one of their excipients;\\n7. Any history or presence of severe hepatic insufficiency and/or of hepatic disease which could lead to hepatic insufficiency;\\n8. Patients who are pregnant or breastfeeding. Patients should not be enrolled if they plan to become pregnant during the time of study participation;\\n9. Any drug intake during the last month prior to the first administration except treatments for concomitant pathologies which are stable since at least 3 months; Benzodiazepine-type anxiolytics, hydroxyzine chlorhydrate, and add-on treatments are authorized within limits described in Section 5.3; For the previous drug intake, the investigator should consider the time needed to sufficiently eliminate a drug from body system, e.g. 5 half-lives of the drug;\\n10. Subjects who received MAOI in monotherapy right before the selection (as ttX);\\n11. General anesthesia within 3 months before administration;\\n12. Major surgery within 28 days prior to randomization or major surgery planned during the next 6 months;\\n13. Positive HBs antigen or anti HCV antibody, or positive results for HIV 1 or 2 tests;\\n14. Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant, calculated creatinine clearance ≤ 60 mL/min;\\n15. Blood donation (including in the frame of a clinical trial) within 2 months before administration;\\n16. Subject who, in the judgment of the Investigator, is likely to be non-compliant or uncooperative during the study, or unable to cooperate because of a language problem, poor mental development;\\n17. Medical history which in the opinion of the investigator would make the patient unsuitable for participation in the study (including, but not limited, to patients with coronary insufficiency, thromboembolism diseases);\\n18. Exclusion period of a previous study;\\n19. No possibility of contact in case of emergency;\\n20. History or presence of drug or alcohol abuse (alcohol consumption \\\\> 40 g/day);\\n21. Administrative or legal supervision.\", 'sex': 'ALL', 'minimumAge': '18 Years', 'maximumAge': '80 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'CHU Angers', 'city': 'Angers', 'country': 'France'}, {'facility': 'CHU Besançon', 'city': 'Besançon', 'country': 'France'}, {'facility': 'CHD Vendée', 'city': 'La Roche-sur-Yon', 'country': 'France'}, {'facility': 'Hôpital Fontan 1', 'city': 'Lille', 'country': 'France'}, {'facility': 'CHU Nantes', 'city': 'Nantes', 'country': 'France'}, {'facility': 'APHP Hôpital La Pitié Salpétrière - Prinicipal investigator center', 'city': 'Paris', 'country': 'France'}, {'facility': 'Hôpital Ste Anne', 'city': 'Paris', 'country': 'France'}, {'facility': 'CHU Henri Laborit', 'city': 'Poitiers', 'country': 'France'}, {'facility': 'CHRU Tours', 'city': 'Tours', 'country': 'France'}, {'facility': 'Cabinet Médical Ambroise Paré', 'city': 'Élancourt', 'country': 'France'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT05612776', 'briefTitle': 'HIIT vs HRV-based Training for Rehabilitation After Stroke', 'officialTitle': 'High Intensity Interval Training (HIIT) vs Heart Rate Variability (HRV) Training for Cardiac and Functional Rehabilitation After Stroke'}, 'statusModule': {'overallStatus': 'UNKNOWN', 'startDateStruct': {'date': '2022-12-01'}, 'primaryCompletionDateStruct': {'date': '2023-08-01'}, 'completionDateStruct': {'date': '2023-12-01'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Universidad de Almeria'}, 'collaborators': [{'name': 'CEINSA, University of Almeria', 'class': 'UNKNOWN'}]}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'enrollmentInfo': {'count': 60}}, 'armsInterventionsModule': {'interventions': [{'type': 'OTHER', 'name': 'HIIT'}, {'type': 'OTHER', 'name': 'HRV'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Inclusion Criteria:\\n\\n* left ejection fraction higher than 30% after stroke\\n* aged between 18 and 80 years old\\n\\nExclusion Criteria:\\n\\n* presence of absolute or relative contraindications for accomplishing the treadmill test, indicated by the Spanish Society of Cardiology\\n* being treated for other diseases, or regularly taking a drug(s) that has a direct or indirect effect on the nervous system (e.g., anxiolytics, antidepressants or neuroleptics)\\n* absence of medication to control the cardiovascular disease or its modification during the intervention\\n* people who are participating or have participated in the previous three months in other similar exercise programs\\n* not performing at least 80% of the workouts during the intervention', 'sex': 'ALL', 'minimumAge': '18 Years', 'maximumAge': '80 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'CITE III', 'city': 'Almería', 'country': 'Spain'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT06655376', 'briefTitle': 'Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients with Assist Device', 'officialTitle': 'Delayed ARIES: Aspirin and Hemocompatibility Events in Advanced Heart Failure Patients Chronically Supported with a Left Ventricular Assist Device'}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2024-10-02'}, 'primaryCompletionDateStruct': {'date': '2027-04-01'}, 'completionDateStruct': {'date': '2027-04-01'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Columbia University'}, 'collaborators': [{'name': 'Weill Medical College of Cornell University', 'class': 'OTHER'}]}, 'designModule': {'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'enrollmentInfo': {'count': 128}}, 'armsInterventionsModule': {'interventions': [{'type': 'DRUG', 'name': 'Aspirin'}, {'type': 'DRUG', 'name': 'Warfarin'}]}, 'eligibilityModule': {'eligibilityCriteria': \"Inclusion Criteria:\\n\\n* Participant will have HeartMate3 LVAD implanted \\\\> 3 months before enrollment.\\n* \\\\>18 years old\\n* Treated with aspirin and VKA\\n* Participant must provide written informed consent prior to any clinical investigation-related procedure\\n\\nExclusion Criteria:\\n\\n* Investigator-mandated antiplatelet therapy for other conditions (including mandated presence or absence of antiplatelet agent)\\n* Participation in any other clinical investigation(s) involving an MCS device, or interventional investigation(s) likely to confound study results or affect study outcome\\n* Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results\\n* Pregnant and on appropriate contraception\", 'sex': 'ALL', 'minimumAge': '18 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'Columbia Irving Medical Center', 'city': 'New York', 'country': 'United States'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT03894176', 'briefTitle': 'Association of Plasma PTX3 Concentration and Outcomes of STEMI', 'officialTitle': 'Association of Plasma Pentraxin 3 Concentration With Angiographic and Clinical Outcomes in STEMI Treated by Primary Angioplasty'}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2018-01-01'}, 'primaryCompletionDateStruct': {'date': '2018-08-02'}, 'completionDateStruct': {'date': '2018-09-02'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Indonesian Cardiovascular Research Center'}}, 'designModule': {'studyType': 'OBSERVATIONAL', 'enrollmentInfo': {'count': 335}}, 'armsInterventionsModule': {'interventions': [{'type': 'OTHER', 'name': 'Plasma PTX3 concentration'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Inclusion Criteria:\\n\\n* Patients with acute STEMI with symptom onset \\\\<12 h undergoing primary PCI\\n\\nExclusion Criteria:\\n\\n* Acute STEMI patients who received fibrinolytic therapy', 'sex': 'ALL'}, 'contactsLocationsModule': {'locations': [{'facility': 'Indonesian Cardiovascular Research Center', 'city': 'Jakarta', 'country': 'Indonesia'}]}}, 'hasResults': False}, {'protocolSection': {'identificationModule': {'nctId': 'NCT05836376', 'briefTitle': 'Is Mitral Annuloplasty an Effective Treatment for Severe Atrial Functional MR?', 'officialTitle': 'Is Mitral Annuloplasty an Effective Treatment for Severe Atrial Functional MR?'}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2020-11-30'}, 'primaryCompletionDateStruct': {'date': '2020-12-02'}, 'completionDateStruct': {'date': '2020-12-02'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Michele De Bonis'}}, 'designModule': {'studyType': 'OBSERVATIONAL', 'enrollmentInfo': {'count': 55}}, 'armsInterventionsModule': {'interventions': [{'type': 'PROCEDURE', 'name': 'Mitral valve annuloplasty'}]}, 'eligibilityModule': {'eligibilityCriteria': 'Atrial MR group Inclusion criteria\\n\\n* Adult patients, underwent mitral annuloplasty for atrial functional mitral Anatomical criteria\\n* Annular dilatation with anterior-posterior diameter (AP) in systole \\\\>35mm\\n* Ratio of AP diameter in systole to anterior leaflet length in diastole \\\\>1.3\\n* Normal leaflets anatomy\\n* Mild fibrosis may be present\\n* A small cleft may be present as a result of annular dilatation Functional criteria\\n* Normal leaflet mobility (Carpentier type I)\\n* Coaptation depth \\\\<10mm\\n* Absence of ventricular tethering\\n* Centrality of the regurgitant jet Atrial and ventricular characteristics\\n* Left atrium diameter \\\\> 40 mm\\n* Normal systolic function of the left ventricle\\n* Mild left ventricular systolic dysfunction Mild LV (tachycardia induced) with EF \\\\>45%\\n* Absence of regional abnormalities in left ventricular wall motion Clinical criteria\\n* Persistent, long-standing persistent, or permanent atrial fibrillation\\n\\nExclusion criteria\\n\\n* Degenerative MR including congenital clefts\\n* LVEF \\\\< 45%\\n* Ventricular tethering\\n* Coaptation depth \\\\>10 mm\\n* Regional abnormalities in left ventricular wall motion\\n* Sinus rhythm\\n* Presence of coronary artery disease\\n* Absence of annular dilatation\\n\\nNon-atrial MR group Inclusion criteria\\n\\n* Adult patients underwent cardiac surgery for non-atrial functional mitral regurgitation in the setting of an idiopathic or ischemic cardiomyopathy\\n\\nExclusion criteria\\n\\n* FE\\\\<40%\\n* Concomitant coronary artery bypass graft\\n* Age \\\\<65 years and \\\\>75years\\n* Treated with annuloplasty + edge-to-edge surgery\\n* Sinus rhythm', 'sex': 'ALL', 'minimumAge': '18 Years'}, 'contactsLocationsModule': {'locations': [{'facility': 'IRCCS Ospedale San Raffaele', 'city': 'Milan', 'country': 'Italy'}]}}, 'hasResults': False}], 'nextPageToken': 'NF0g5JqFkQ'}\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "         NCTId                                         BriefTitle  \\\n",
              "0  NCT03437876  Study on Effect of Intestinal Microbiota Trans...   \n",
              "1  NCT00252876  GALLEX 1 - Long Term Extension Study in Patien...   \n",
              "2  NCT06621576  First-in-Human Pilot Study of Epicardial Circu...   \n",
              "3  NCT02312076  GnRHa for Luteal Phase Support in Long GnRHa P...   \n",
              "4  NCT05125276  Less Bleeding by Omitting Aspirin in Non-ST-se...   \n",
              "5  NCT03870776  RESIST : Administration of MAP4343 in Antidepr...   \n",
              "6  NCT05612776  HIIT vs HRV-based Training for Rehabilitation ...   \n",
              "7  NCT06655376  Aspirin and Hemocompatibility Events in Chroni...   \n",
              "8  NCT03894176  Association of Plasma PTX3 Concentration and O...   \n",
              "9  NCT05836376  Is Mitral Annuloplasty an Effective Treatment ...   \n",
              "\n",
              "           OverallStatus         Phase   StartDate CompletionDate  \\\n",
              "0                UNKNOWN            NA  2016-10-31        2020-12   \n",
              "1             TERMINATED        PHASE3     2005-03        2007-01   \n",
              "2  ACTIVE_NOT_RECRUITING  EARLY_PHASE1  2024-09-18        2025-09   \n",
              "3             RECRUITING        PHASE4  2016-09-09     2024-12-31   \n",
              "4             RECRUITING        PHASE4  2022-05-13        2025-07   \n",
              "5  ACTIVE_NOT_RECRUITING        PHASE2  2019-06-01     2025-03-01   \n",
              "6                UNKNOWN            NA  2022-12-01     2023-12-01   \n",
              "7             RECRUITING        PHASE4  2024-10-02     2027-04-01   \n",
              "8              COMPLETED           N/A  2018-01-01     2018-09-02   \n",
              "9              COMPLETED           N/A  2020-11-30     2020-12-02   \n",
              "\n",
              "   EnrollmentCount                                    LeadSponsorName  \n",
              "0               60               Zhongshan Hospital Xiamen University  \n",
              "1             2000                                        AstraZeneca  \n",
              "2                3                                    Ruijin Hospital  \n",
              "3              200                                Mansoura University  \n",
              "4             3090  Academisch Medisch Centrum - Universiteit van ...  \n",
              "5              110                                             Mapreg  \n",
              "6               60                             Universidad de Almeria  \n",
              "7              128                                Columbia University  \n",
              "8              335          Indonesian Cardiovascular Research Center  \n",
              "9               55                                   Michele De Bonis  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-e65bc490-36f2-4418-a8ad-1195caa2f74d\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NCTId</th>\n",
              "      <th>BriefTitle</th>\n",
              "      <th>OverallStatus</th>\n",
              "      <th>Phase</th>\n",
              "      <th>StartDate</th>\n",
              "      <th>CompletionDate</th>\n",
              "      <th>EnrollmentCount</th>\n",
              "      <th>LeadSponsorName</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NCT03437876</td>\n",
              "      <td>Study on Effect of Intestinal Microbiota Trans...</td>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NA</td>\n",
              "      <td>2016-10-31</td>\n",
              "      <td>2020-12</td>\n",
              "      <td>60</td>\n",
              "      <td>Zhongshan Hospital Xiamen University</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NCT00252876</td>\n",
              "      <td>GALLEX 1 - Long Term Extension Study in Patien...</td>\n",
              "      <td>TERMINATED</td>\n",
              "      <td>PHASE3</td>\n",
              "      <td>2005-03</td>\n",
              "      <td>2007-01</td>\n",
              "      <td>2000</td>\n",
              "      <td>AstraZeneca</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NCT06621576</td>\n",
              "      <td>First-in-Human Pilot Study of Epicardial Circu...</td>\n",
              "      <td>ACTIVE_NOT_RECRUITING</td>\n",
              "      <td>EARLY_PHASE1</td>\n",
              "      <td>2024-09-18</td>\n",
              "      <td>2025-09</td>\n",
              "      <td>3</td>\n",
              "      <td>Ruijin Hospital</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NCT02312076</td>\n",
              "      <td>GnRHa for Luteal Phase Support in Long GnRHa P...</td>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>PHASE4</td>\n",
              "      <td>2016-09-09</td>\n",
              "      <td>2024-12-31</td>\n",
              "      <td>200</td>\n",
              "      <td>Mansoura University</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NCT05125276</td>\n",
              "      <td>Less Bleeding by Omitting Aspirin in Non-ST-se...</td>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>PHASE4</td>\n",
              "      <td>2022-05-13</td>\n",
              "      <td>2025-07</td>\n",
              "      <td>3090</td>\n",
              "      <td>Academisch Medisch Centrum - Universiteit van ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>NCT03870776</td>\n",
              "      <td>RESIST : Administration of MAP4343 in Antidepr...</td>\n",
              "      <td>ACTIVE_NOT_RECRUITING</td>\n",
              "      <td>PHASE2</td>\n",
              "      <td>2019-06-01</td>\n",
              "      <td>2025-03-01</td>\n",
              "      <td>110</td>\n",
              "      <td>Mapreg</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>NCT05612776</td>\n",
              "      <td>HIIT vs HRV-based Training for Rehabilitation ...</td>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NA</td>\n",
              "      <td>2022-12-01</td>\n",
              "      <td>2023-12-01</td>\n",
              "      <td>60</td>\n",
              "      <td>Universidad de Almeria</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>NCT06655376</td>\n",
              "      <td>Aspirin and Hemocompatibility Events in Chroni...</td>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>PHASE4</td>\n",
              "      <td>2024-10-02</td>\n",
              "      <td>2027-04-01</td>\n",
              "      <td>128</td>\n",
              "      <td>Columbia University</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>NCT03894176</td>\n",
              "      <td>Association of Plasma PTX3 Concentration and O...</td>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>N/A</td>\n",
              "      <td>2018-01-01</td>\n",
              "      <td>2018-09-02</td>\n",
              "      <td>335</td>\n",
              "      <td>Indonesian Cardiovascular Research Center</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>NCT05836376</td>\n",
              "      <td>Is Mitral Annuloplasty an Effective Treatment ...</td>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>N/A</td>\n",
              "      <td>2020-11-30</td>\n",
              "      <td>2020-12-02</td>\n",
              "      <td>55</td>\n",
              "      <td>Michele De Bonis</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-e65bc490-36f2-4418-a8ad-1195caa2f74d')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-e65bc490-36f2-4418-a8ad-1195caa2f74d button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-e65bc490-36f2-4418-a8ad-1195caa2f74d');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-75b7f6c5-d99f-4159-a7e9-fcc06330c170\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-75b7f6c5-d99f-4159-a7e9-fcc06330c170')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-75b7f6c5-d99f-4159-a7e9-fcc06330c170 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_f307f1b9-6476-416f-a89d-6dfe5687192c\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_f307f1b9-6476-416f-a89d-6dfe5687192c button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 10,\n  \"fields\": [\n    {\n      \"column\": \"NCTId\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [\n          \"NCT03894176\",\n          \"NCT00252876\",\n          \"NCT03870776\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefTitle\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [\n          \"Association of Plasma PTX3 Concentration and Outcomes of STEMI\",\n          \"GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes\",\n          \"RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"OverallStatus\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"TERMINATED\",\n          \"COMPLETED\",\n          \"ACTIVE_NOT_RECRUITING\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Phase\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"NA\",\n          \"PHASE3\",\n          \"N/A\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"StartDate\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [\n          \"2018-01-01\",\n          \"2005-03\",\n          \"2019-06-01\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"CompletionDate\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [\n          \"2018-09-02\",\n          \"2007-01\",\n          \"2025-03-01\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"EnrollmentCount\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1058,\n        \"min\": 3,\n        \"max\": 3090,\n        \"num_unique_values\": 9,\n        \"samples\": [\n          335,\n          2000,\n          110\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"LeadSponsorName\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [\n          \"Indonesian Cardiovascular Research Center\",\n          \"AstraZeneca\",\n          \"Mapreg\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {}
        }
      ],
      "source": [
        "import requests\n",
        "import pandas as pd\n",
        "from IPython.display import display\n",
        "\n",
        "# ✅ API のエンドポイント\n",
        "BASE_URL = \"https://clinicaltrials.gov/api/v2/studies\"\n",
        "\n",
        "# ✅ 正しいフィールドリスト（コメントアウトで簡単に制御）\n",
        "fields_list = [\n",
        "    \"NCTId\",\n",
        "    \"BriefTitle\",\n",
        "    \"OfficialTitle\",  # 基本情報\n",
        "    \"OverallStatus\",\n",
        "    \"Phase\",  # 試験の状態\n",
        "    \"StartDate\",\n",
        "    \"PrimaryCompletionDate\",\n",
        "    \"CompletionDate\",  # 期間情報\n",
        "    \"EnrollmentCount\",\n",
        "    \"EligibilityCriteria\",\n",
        "    \"Gender\",\n",
        "    \"MinimumAge\",\n",
        "    \"MaximumAge\",  # 参加条件\n",
        "    \"StudyType\",\n",
        "    \"InterventionType\",\n",
        "    \"InterventionName\",  # 研究タイプ & 介入情報\n",
        "    \"LocationCountry\",\n",
        "    \"LocationCity\",\n",
        "    \"LocationFacility\",  # 実施場所情報\n",
        "    \"HasResults\",\n",
        "    \"ResultsFirstPostDate\",  # 試験結果情報\n",
        "    \"LeadSponsorName\",\n",
        "    \"Collaborator\"  # スポンサー情報\n",
        "]\n",
        "\n",
        "params = {\n",
        "    \"query.term\": \"heart disease\",\n",
        "    \"pageSize\": 10,  # まずは 10 件取得\n",
        "    \"fields\": \",\".join(fields_list)\n",
        "}\n",
        "\n",
        "response = requests.get(BASE_URL, params=params, headers={\"Accept\": \"application/json\"})\n",
        "\n",
        "if response.status_code == 200:\n",
        "    data = response.json()\n",
        "\n",
        "    print(\"📌 APIレスポンスの一部を確認:\")\n",
        "    print(data)  # レスポンスデータ全体を確認\n",
        "\n",
        "    studies = data.get(\"studies\", [])\n",
        "\n",
        "    if not studies:\n",
        "        print(\"⚠️ 取得データが空です！検索条件を変えて試してください。\")\n",
        "    else:\n",
        "        extracted_data = []\n",
        "        for study in studies:\n",
        "            extracted_data.append({\n",
        "                \"NCTId\": study[\"protocolSection\"][\"identificationModule\"].get(\"nctId\", \"N/A\"),\n",
        "                \"BriefTitle\": study[\"protocolSection\"][\"identificationModule\"].get(\"briefTitle\", \"N/A\"),\n",
        "                \"OverallStatus\": study[\"protocolSection\"][\"statusModule\"].get(\"overallStatus\", \"N/A\"),\n",
        "                \"Phase\": study[\"protocolSection\"][\"designModule\"].get(\"phases\", [\"N/A\"])[0],  # フェーズはリスト\n",
        "                \"StartDate\": study[\"protocolSection\"][\"statusModule\"].get(\"startDateStruct\", {}).get(\"date\", \"N/A\"),\n",
        "                \"CompletionDate\": study[\"protocolSection\"][\"statusModule\"].get(\"completionDateStruct\", {}).get(\"date\", \"N/A\"),\n",
        "                \"EnrollmentCount\": study[\"protocolSection\"][\"designModule\"].get(\"enrollmentInfo\", {}).get(\"count\", \"N/A\"),\n",
        "                \"LeadSponsorName\": study[\"protocolSection\"][\"sponsorCollaboratorsModule\"][\"leadSponsor\"].get(\"name\", \"N/A\"),\n",
        "            })\n",
        "\n",
        "        df = pd.DataFrame(extracted_data)\n",
        "        display(df)\n",
        "\n",
        "else:\n",
        "    print(f\"❌ APIリクエストエラー: {response.status_code}\")\n",
        "    print(response.text)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(df.head)  # 取得したデータをそのまま確認"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "T4FXCtk-HyS2",
        "outputId": "c6f1eab1-42b3-4494-b340-9cdc00fa404c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<bound method NDFrame.head of          NCTId                                         BriefTitle  \\\n",
            "0  NCT03437876  Study on Effect of Intestinal Microbiota Trans...   \n",
            "1  NCT00252876  GALLEX 1 - Long Term Extension Study in Patien...   \n",
            "2  NCT06621576  First-in-Human Pilot Study of Epicardial Circu...   \n",
            "3  NCT02312076  GnRHa for Luteal Phase Support in Long GnRHa P...   \n",
            "4  NCT05125276  Less Bleeding by Omitting Aspirin in Non-ST-se...   \n",
            "5  NCT03870776  RESIST : Administration of MAP4343 in Antidepr...   \n",
            "6  NCT05612776  HIIT vs HRV-based Training for Rehabilitation ...   \n",
            "7  NCT06655376  Aspirin and Hemocompatibility Events in Chroni...   \n",
            "8  NCT03894176  Association of Plasma PTX3 Concentration and O...   \n",
            "9  NCT05836376  Is Mitral Annuloplasty an Effective Treatment ...   \n",
            "\n",
            "           OverallStatus         Phase   StartDate CompletionDate  \\\n",
            "0                UNKNOWN            NA  2016-10-31        2020-12   \n",
            "1             TERMINATED        PHASE3     2005-03        2007-01   \n",
            "2  ACTIVE_NOT_RECRUITING  EARLY_PHASE1  2024-09-18        2025-09   \n",
            "3             RECRUITING        PHASE4  2016-09-09     2024-12-31   \n",
            "4             RECRUITING        PHASE4  2022-05-13        2025-07   \n",
            "5  ACTIVE_NOT_RECRUITING        PHASE2  2019-06-01     2025-03-01   \n",
            "6                UNKNOWN            NA  2022-12-01     2023-12-01   \n",
            "7             RECRUITING        PHASE4  2024-10-02     2027-04-01   \n",
            "8              COMPLETED           N/A  2018-01-01     2018-09-02   \n",
            "9              COMPLETED           N/A  2020-11-30     2020-12-02   \n",
            "\n",
            "   EnrollmentCount                                    LeadSponsorName  \n",
            "0               60               Zhongshan Hospital Xiamen University  \n",
            "1             2000                                        AstraZeneca  \n",
            "2                3                                    Ruijin Hospital  \n",
            "3              200                                Mansoura University  \n",
            "4             3090  Academisch Medisch Centrum - Universiteit van ...  \n",
            "5              110                                             Mapreg  \n",
            "6               60                             Universidad de Almeria  \n",
            "7              128                                Columbia University  \n",
            "8              335          Indonesian Cardiovascular Research Center  \n",
            "9               55                                   Michele De Bonis  >\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "tCQYPgLyFT78"
      }
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "og_OUVRvFT40"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "\n",
        "# ステータスごとのカウント\n",
        "status_counts = df[\"OverallStatus\"].value_counts()\n",
        "\n",
        "# グラフ作成\n",
        "plt.figure(figsize=(8, 5))\n",
        "status_counts.plot(kind=\"bar\")\n",
        "plt.title(\"Clinical Trials Status Distribution\")\n",
        "plt.xlabel(\"Status\")\n",
        "plt.ylabel(\"Number of Trials\")\n",
        "plt.xticks(rotation=45)\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 546
        },
        "id": "i5YeFpFG_l49",
        "outputId": "a44d649a-b6b5-4711-ef74-cb4a6d9be456"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x500 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "GET /api/query/full_studies"
      ],
      "metadata": {
        "id": "_bJiC1KW93tE"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "y9lvxpXw9u0T"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}